01—Abstract
Summary
Summary of the 8-K filed May 13, 2026. Cited figures are marked; the original filing is the authoritative source.
Elevance Health, Inc. (ELV) held its Annual Meeting of Shareholders on May 13, 2026, with a substantial quorum represented by over 194 million shares of common stock.
The meeting's primary outcomes included the overwhelming election of directors, with all nominees securing significant support and terms extending to 2029. This demonstrates continued confidence in the leadership team guiding the company's strategic direction. Furthermore, shareholders provided advisory approval for the company's executive compensation practices, signaling alignment between executive pay and company performance.
The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 was also ratified, reinforcing established audit procedures. Notably, a shareholder proposal seeking an independent study on prohibiting corporate contributions to partisan 527 political groups did not receive sufficient support for approval, indicating shareholder sentiment against such an initiative at this time.
02—Key points
Key Highlights
- All director nominees were overwhelmingly elected for three-year terms expiring in 2029, indicating strong shareholder confidence in governance.
- Shareholders provided advisory approval for the company's executive compensation, with a significant majority voting in favor.
- The appointment of Ernst & Young LLP as the independent auditor for fiscal year 2026 was ratified by a substantial margin.
- A quorum was established with 194,441,339 shares of common stock represented at the Annual Meeting.
- A shareholder proposal to study the impact of prohibiting corporate contributions to partisan 527 political groups was not approved by shareholders.
- Director Gail K. Boudreaux received a commanding 'For' vote count, highlighting strong support for her leadership.
03—Questions
Frequently Asked Questions
What were the key outcomes of the Elevance Health Annual Meeting on May 13, 2026?
The key outcomes included the election of directors, advisory approval of executive compensation, ratification of the independent auditor (Ernst & Young LLP), and the rejection of a shareholder proposal regarding political contributions.
How did shareholders vote on the election of directors?
All nominees for director were overwhelmingly elected for three-year terms. For instance, Gail K. Boudreaux received over 177 million 'For' votes, with minimal opposition, abstentions, or broker non-votes.
What was the shareholder sentiment on executive compensation?
Shareholders voted in an advisory capacity to approve the company's executive compensation. The 'For' votes significantly outweighed the 'Against' votes, indicating general satisfaction with the executive pay structure.
Did the shareholder proposal regarding political contributions pass?
No, the shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups did not receive sufficient votes to be approved.
04—Continue